High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test
- PMID: 20538837
- PMCID: PMC2924420
- DOI: 10.2215/CJN.01790210
High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test
Abstract
Background and objectives: Patients in ESRD on hemodialysis with latent tuberculosis (TB) infection have 10 to 25 times the risk of reactivation into active disease compared with healthy adults. This study investigates the prevalence of latent TB infection in dialysis patients from a country with an intermediate burden of TB and its associated risk factors using the QuantiFERON-TB Gold in-tube test (QGIT) and the tuberculin skin test (TST).
Design, setting, participants, & measurements: This was a prospective, cross-sectional study performed at a medical center in Taiwan on dialysis patients. Each patient underwent QGIT, two-step TST using 2 tuberculin units (TU) of PPD RT-23, a chest x-ray to exclude active TB, and an interview to determine TB risk factors.
Results: Ninety-three of 190 eligible patients were enrolled: 35 men and 58 women. 64.8% were vaccinated with the Bacille-Calmette-Guérin (BCG) vaccination. Overall, 34.4% were positive by QGIT and 10.8% were indeterminate. Using a 10-mm TST cutoff, 53.9% were positive. There was poor correlation between TST and QGIT at any TST cutoff criteria. There was a significant increasing trend of QGIT positivity with age in those younger than 70 years, and, conversely, a decreasing trend of TST reactivity with age. Significant risk factors for QGIT positivity included age and past TB disease.
Conclusions: This study shows a high prevalence of latent TB infection in dialysis patients in a country with an intermediate burden of TB. QGIT in dialysis patients correlated better than TST with the risk of TB infection and past TB disease.
Figures
Similar articles
-
Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.J Microbiol Immunol Infect. 2016 Oct;49(5):729-736. doi: 10.1016/j.jmii.2014.08.010. Epub 2014 Nov 1. J Microbiol Immunol Infect. 2016. PMID: 25442858
-
Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.J Microbiol Immunol Infect. 2015 Apr;48(2):147-52. doi: 10.1016/j.jmii.2013.07.008. Epub 2013 Sep 23. J Microbiol Immunol Infect. 2015. PMID: 24071516
-
High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.Infection. 2009 Apr;37(2):96-102. doi: 10.1007/s15010-008-8082-3. Epub 2008 Dec 10. Infection. 2009. PMID: 19139810
-
Tests for latent tuberculosis in people with ESRD: a systematic review.Am J Kidney Dis. 2013 Jan;61(1):33-43. doi: 10.1053/j.ajkd.2012.07.019. Epub 2012 Oct 13. Am J Kidney Dis. 2013. PMID: 23068425 Review.
-
Diagnosis of tuberculosis in dialysis patients: current strategy.Clin J Am Soc Nephrol. 2010 Jun;5(6):1114-22. doi: 10.2215/CJN.09231209. Epub 2010 Apr 22. Clin J Am Soc Nephrol. 2010. PMID: 20413440 Review.
Cited by
-
Diabetes mellitus and latent tuberculosis infection: an updated meta-analysis and systematic review.BMC Infect Dis. 2023 Nov 8;23(1):770. doi: 10.1186/s12879-023-08775-y. BMC Infect Dis. 2023. PMID: 37940866 Free PMC article.
-
The prevalence of latent tuberculosis infection in patients with chronic kidney disease: A systematic review and meta-analysis.Heliyon. 2023 Jun 10;9(6):e17181. doi: 10.1016/j.heliyon.2023.e17181. eCollection 2023 Jun. Heliyon. 2023. PMID: 37484241 Free PMC article.
-
Prevalence of Latent Tuberculosis Infection among Patients Undergoing Regular Hemodialysis in Disenfranchised Communities: A Multicenter Study during COVID-19 Pandemic.Medicina (Kaunas). 2023 Mar 26;59(4):654. doi: 10.3390/medicina59040654. Medicina (Kaunas). 2023. PMID: 37109612 Free PMC article.
-
Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients.Front Cell Infect Microbiol. 2022 Nov 14;12:1046373. doi: 10.3389/fcimb.2022.1046373. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36452296 Free PMC article.
-
Early diagnosis of miliary tuberculosis in a hemodialysis patient by combining two interferon-γ-release assays: a case report.BMC Nephrol. 2020 Jun 4;21(1):214. doi: 10.1186/s12882-020-01875-w. BMC Nephrol. 2020. PMID: 32498706 Free PMC article.
References
-
- Global Tuberculosis Control, 2009: Epidemiology, Strategy, Financing, Geneva, Switzerland, World Health Organization Press, 2009
-
- Taiwan Tuberculosis Control Report, 2009, Taipei, Taiwan, Centers for Disease Control, 2009
-
- U.S. Renal Data System: USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
-
- Chou KJ, Fang HC, Bai KJ, Hwang SJ, Yang WC, Chung HM: Tuberculosis in maintenance dialysis patients. Nephron 88: 138–143, 2001 - PubMed
-
- Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I: Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20: 440–451, 2007 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
